Betnovate Ointment Glaxosmithkline
| Features | |
| Acne | No |
| Active substance | Betamethasone |
| Also known as | Betamethasone sodium phosphate, Betamethasone acetate |
| Aromatization | No |
| Blood pressure | Can increase blood pressure, monitoring advised |
| Chemical name | 9-fluoro-11ОІ,17,21-trihydroxy-16ОІ-methylpregna-1,4-diene-3,20-dione |
| Classification | anti-inflammatory |
| Dosage (medical) | Dosage varies, typical initial dosages may range from 0.6 to 7.2 mg daily depending on the condition being treated |
| Dosage (sports) | Not applicable for performance enhancement as its use is generally for medical treatment only |
| Effects | Reduces inflammation, suppresses the immune response |
| Formula | C22H29FO5 |
| Half-life | 36-54 hours |
| HBR | No |
| Hepatotoxicity | No |
| Lab Test | Monitoring may include adrenal function tests and bone density scans for long-term users |
| Main action | Anti-inflammatory and immunosuppressant |
| Side effects | Long-term use can lead to side effects like osteoporosis, adrenal suppression, muscle weakness, ulcerative esophagitis, and psychological effects such as mood swings |
| Storage conditions | Store at controlled room temperature, away from light and moisture |
| Substance class | Corticosteroid |
| Trade name | Celestone, Betnesol, others |
| Use in sports | Primarily used for therapeutic purposes to treat inflammation and manage symptoms of chronic conditions |
| WAREHOUSE | International Warehouse 2 |
| Water Retention | No |
| Manufacturer | GSK |